Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients.
Fiorino G, Correale C, Radice S, Allocca M, Furfaro F, Gilardi D, Nagore D, Del Rio L, Pascual J, Martínez A, Danese S.
Fiorino G, et al. Among authors: gilardi d.
Aliment Pharmacol Ther. 2017 Nov;46(9):903-905. doi: 10.1111/apt.14262.
Aliment Pharmacol Ther. 2017.
PMID: 29023889
No abstract available.